AlphaGrade Open the live NVO card →

NVO Novo Nordisk A/S

$40.19-0.64%
Live score · Nov 3, 2026 · 23:12 UTC
Conviction
62 / 100
Neutral
Market regime: Risk-Off
DCF fair value$79.8199% upside to fair valuemodel estimate
Quality82
ROIC vs WACC · FCF yield · margins · moat · balance sheet
Setup43
trend · relative strength · RSI · accumulation · momentum
Convex2.6
demand signals · capacity · catalysts · asymmetric upside
Macro Regime1.5
liquidity · credit · breadth · volatility · sentiment
Price vs. fundamentals · 1Y
Bars = the fundamental (held per quarter); the line is price.

AlphaGrade rates Novo Nordisk A/S Neutral, with a conviction of 62/100. Fundamental quality looks strong and the technical setup looks weak, with some asymmetric upside — blended with the current market regime.

The work behind the score
Quality82
ROIC vs WACC100
Moat Strength86
FCF Yield100
Financial Health82
Debt Health87
Growth & Orders29
Execution & Delivery24
Analyst Price Target61
Setup43
Relative Strength10
Trend Health0
RSI Momentum62
Estimate Revisions15
Post-Earnings Reaction74
Valuation Blend35
Catalyst Proximity100
Insider Activity55
Analyst Sentiment45
Estimate Dispersion Velocityn/a
Institutional Flow (13F)85
Short-Volume Velocity55
Sector Momentum100
Convex2.6
DCF Upside92
Orders & Demand29
Capacity Constraints17
Catalyst Window100
Short Interest33
Capex Trend Acceleration59
Political Trade Flow52
Macro1.5
Liquidity 6%Credit 4%Breadth 67%Volatility 60%Sentiment 25%Leadership 31% How the regime works →
Recomputed from live fundamentals & price data. AlphaGrade blends 34 individual tests across four dimensions with the current market regime. Not a static rating.

Ask Alpha about NVO, see the price-vs-fundamentals charts, and find out how it fits your portfolio.

Open NVO in AlphaGrade — free

Every test explained, and the full chart. No account needed.

NVO grade — FAQ

Is NVO a buy right now?

Novo Nordisk A/S (NVO) has an AlphaGrade conviction of 62/100 — Neutral — as of Nov 3, 2026 · 23:12 UTC, in the current Risk-Off market regime. AlphaGrade rates Novo Nordisk A/S Neutral, with a conviction of 62/100. Fundamental quality looks strong and the technical setup looks weak, with some asymmetric upside — blended with the current market regime. This is a transparent, rules-based research opinion, not financial advice.

What is NVO's AlphaGrade?

NVO's conviction is 62/100 (Neutral), built from Quality 82/100, Setup 43/100, and Convex 2.6/5, then adjusted for the market regime.

How is the NVO grade calculated?

AlphaGrade blends 34 individual tests across four dimensions: Quality (business fundamentals), Setup (technical timing), Convex (asymmetric upside), and the macro regime, recomputed from live data.

AlphaGrade is for research/education, not financial advice. · alphagrade.io